Prefilled Auto Injectors Market
Prefilled Auto Injectors Market Study by Anaphylaxis, Multiple Sclerosis, and Rheumatoid Arthritis from 2023 to 2033
Analysis of Prefilled Auto Injectors Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Prefilled Auto Injectors Market Outlook (2023 to 2033)
Expanding at a high-value CAGR of 15%, the global prefilled auto injectors market is extrapolated to attain a valuation of US$ 17 billion by 2033-end, up from its current size of US$ 4.2 billion.
Increasing focus on health and growing demand for self-administration of drugs are expected to be prime factors driving the sales of prefilled auto injectors in the future. High incidence of diabetes across the world is also projected to bolster shipments of prefilled insulin pens and prefilled insulin auto injectors across the forecast period (2023 to 2033).
Rising prevalence of several allergic reactions and high demand for injectable allergy medications are also anticipated to positively impact market development going forward. Prefilled injectable epinephrine pens and adrenaline auto injectors are anticipated to witness a hike in sales owing to the high ubiquity of allergic conditions such as anaphylaxis on a global level.
Favourable reimbursement infrastructure, high healthcare expenditure, rising demand for convenient drug delivery devices, increasing investments in healthcare R&D, and the growing availability of innovative and advanced drug delivery technologies are other prospects that are slated to uplift market potential through 2033. Contrastingly, high costs of prefilled auto injectors and strict regulatory laws are anticipated to have an impeding effect on prefilled auto injector sales throughout the forecast period.
A comprehensive assessment of current and forecasted market scenarios detailing factors such as pricing trends, product standards, local supply, safety regulations, global demand, and other key factors has been discussed extensively in this latest prefilled auto injectors industry research survey by Fact.MR, a market research and competitive intelligence provider.
Report Attributes |
Details |
|
Prefilled Auto Injectors Market Size (2023) |
US$ 4.2 Billion |
|
Projected Market Value (2033F) |
US$ 17 Billion |
|
Global Market Growth Rate (2023 to 2033) |
15% CAGR |
|
Asia Pacific Market Growth Rate (2023 to 2033) |
15.8% CAGR |
|
United States Market Share in North America (2022) |
~85% |
|
Key Companies Profiled |
|
Don't Need a Global Report?
save 40%! on Country & Region specific reports
How are Start-ups changing the Route of Drug Delivery?
“New Companies Focusing on Creating Novel Drug Delivery Devices to Improve Healthcare”
Prefilled auto injector start-ups are focusing on acquiring new capital to advance their research and development of novel technologies and fast-track the launch of these innovative products. The new prefilled auto injector manufacturers are also using their funds to develop creative marketing and business strategies that allow them to compete with the established market players.
- In June 2022, Elektrofi, a biotechnology start-up focusing on the development of monoclonal antibodies and therapeutic proteins that could enable the delivery of biologics through auto injectors and prefilled syringes announced that it had raised US$ 40 billion. The new capital was intended to be used to create a GMP manufacturing line and push its drug delivery technology in clinics.
A more detailed account of the current and forecasted start-up scenario along with new developments has been listed in this updated prefilled auto injectors market research report by Fact.MR.
Which Factors May Restrain Prefilled Auto Injectors Market Evolution?
“High Cost of Auto Injectors and Lengthy Approval Process”
The research and development process of auto injectors is a complex one and involves the use of advanced technologies, which drives up the cost of manufacturing as well and results in costly end products. These high costs limit the sales of prefilled auto injectors in developing and underdeveloped economies that have restricted spending potential. Moreover, the lengthy and stringent regulatory mandates also elongate the pre-approval process for several products and result in expensive prefilled auto injectors.
Frequent product recalls by regulatory bodies are also anticipated to have a hindering effect on the overall market growth in the future. The widespread adoption of pre-filled syringes over auto injectors is also predicted to hurt prefilled auto injector sales going forward.
Country-wise Insights
Why is Japan an Investment-worthy Market for Prefilled Auto Injector Vendors?
“Increasing Incidence of Rheumatoid Arthritis among Elderly”
Japan has a high geriatric population that accounts for nearly 1/3 of its total population and this sect is influentially governing healthcare industry trends in the country. Elderly people are more at risk of having joint and bone-related health issues such as Rheumatoid Arthritis and this is a prime factor that is anticipated to boost prefilled auto injector demand in the country over the coming years.
The growing availability of advanced drug delivery technologies, increasing spending on healthcare, supportive government initiatives, and rising disposable income are other factors that could potentially impact market evolution in Japan throughout the forecast period.
- In June 2022, Otsuka Pharmaceutical Co. Ltd., a leading pharmaceutical company in Japan announced that it had received regulatory approval for an auto injector dosage form for AJOVY® Subcutaneous Injection 225 mg. The AJOVY formulation is used as a preventive treatment for migraine in adults, which is developed by Teva Pharmaceuticals and exclusively developed and distributed by Otsuka in Japan.
Which European Countries Should Prefilled Auto Injector Manufacturers Focus On?
“Germany & United Kingdom to Offer Attractive Business Scope”
Focus on healthcare infrastructure development has increased substantially in the European region in recent years owing to the growing prevalence of chronic diseases and increasing awareness regarding preventive healthcare. Germany and the United Kingdom are anticipated to spearhead prefilled auto injector sales in Europe across the forecast period owing to the increasing availability of novel drug delivery devices and high healthcare expenditure.
- In November 2022, Arecor Therapeutics plc’s subsidiary Tetris Pharma Ltd. announced the launch of a glucagon-prefilled auto injector pen called Ogluo® in Germany. The product is used for the treatment of severe hypoglycaemia in adults and children suffering from diabetes.
Increasing focus on reducing needlestick injuries, growing awareness regarding the benefits of prefilled syringes and auto injectors, and high investments in the development of innovative drug delivery technologies are other aspects that shape prefilled auto injector demand outlook in the aforementioned European countries. Rising approvals for new products and changing regulatory frameworks are also expected to have a positive impact on market growth in this region through 2033.
How Will Sales of Prefilled Auto Injectors Fare in the United States?
“Rapid Adoption of Novel Healthcare Technologies in the Country”
Demand for prefilled auto injectors in the United States accounted for more than 85% of the market share in the North American region in 2022 and the country is estimated to maintain a similar dominant stance across the forecast period. A high incidence of diabetes and anaphylaxis is a prime prospect that is projected to uplift prefilled auto injector sales in the country over the coming years.
- As per the statistics listed on the Centers for Disease Control and Prevention website, around 37.3 billion suffered from diabetes in 2022 in the United States, which accounted for around 11.3% of the total population of the country.
High healthcare spending, rapid adoption of novel drug delivery systems, the presence of key prefilled auto injector suppliers, and rising investments in healthcare research and development activities are other aspects that could potentially boost market growth in the future. The presence of favorable reimbursement and insurance policies in the country is also anticipated to promote shipments of prefilled auto injectors over the next ten years.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Category-wise Insights
Which Indication Accounts for High Prefilled Auto Injector Sales?
“Anaphylaxis Accounts for Dominant Market Share”
Based on indication, the market for prefilled auto injectors is segmented into anaphylaxis, multiple sclerosis, rheumatoid arthritis, and others.
Epinephrine injection is extensively used in the treatment of several allergic reactions including anaphylaxis, which is a potentially deadly allergic reaction. Increasing incidence of anaphylaxis across the world is projected to primarily boost demand for epinephrine for its treatment and since it is mostly delivered in the form of pre-filled syringes and auto injectors, it is projected to boost market potential over the coming years.
Auto injectors are preferred for several allergy medications since they can be administered by anyone even without any medical training or background. Growing demand for injectable epinephrine to treat several allergic reactions such as anaphylaxis is anticipated to uplift sales of prefilled auto injectors through 2033.
Competitive Landscape :
Leading prefilled auto injector companies are focusing on developing and launching innovative products that help them in bolstering their market stance and boost sales potential.
- In May 2022, Jabil Healthcare, a healthcare division of Jabil Inc. announced the launch of a new auto injector platform that is modular and more affordable than other market alternatives. The product was launched to support sustainable drug delivery in the pharmaceutical industry landscape.
- In October 2021, Ypsomed a leading medical device manufacturer announced the launch of the world’s first auto injector for prefilled syringes with integrated connectivity. The YpsoMate On utilized the proven expertise of the company’s auto injector and opened up new options for digital therapy support as well.
- In April 2020, Teva Pharmaceuticals USA Inc., a leading pharmaceutical manufacturer announced the launch of an auto injector device for AJOVY® (fremanezumab-vfrm) injection in the United States. The drug was used as a preventive treatment for migraine in adults.
Key Segments of Prefilled Auto Injectors Industry Research
-
By Indication :
- Anaphylaxis
- Multiple Sclerosis
- Rheumatoid Arthritis
- Others
-
By Distribution Channel :
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Drug Stores
-
By Region :
- North America
- Latin America
- Europe
- APAC
- MEA
Table of Content
1. Global Market - Executive Summary 2. Global Market Overview 2.1. Introduction 2.1.1. Global Market Taxonomy 2.1.2. Global Market Definition 2.2. Global Market Size (US$ Mn) and Forecast, 2023-2033 2.2.1. Global Market Y-o-Y Growth 2.3. Global Market Dynamics 2.4. Regulations 2.5. Supply Chain 2.6. Cost Structure 2.7. Average Pricing Analysis 2.8. List of Distributors 2.9. Key Participants Market Presence (Intensity Map) By Region 3. Global Market Analysis and Forecast By Indication 3.1. Global Market Size and Forecast By Indication, 2023-2033 3.1.1. Anaphylaxis Market Size and Forecast, 2023-2033 3.1.1.1. Revenue (US$ Mn) Comparison, By Region 3.1.1.2. Market Share Comparison, By Region 3.1.1.3. Y-o-Y growth Comparison, By Region 3.1.2. Multiple Sclerosis Market Size and Forecast, 2023-2033 3.1.2.1. Revenue (US$ Mn) Comparison, By Region 3.1.2.2. Market Share Comparison, By Region 3.1.2.3. Y-o-Y growth Comparison, By Region 3.1.3. Rheumatoid Arthritis Market Size and Forecast, 2023-2033 3.1.3.1. Revenue (US$ Mn) Comparison, By Region 3.1.3.2. Market Share Comparison, By Region 3.1.3.3. Y-o-Y growth Comparison, By Region 3.1.4. Others Market Size and Forecast, 2023-2033 3.1.4.1. Revenue (US$ Mn) Comparison, By Region 3.1.4.2. Market Share Comparison, By Region 3.1.4.3. Y-o-Y growth Comparison, By Region 4. Global Market Analysis and Forecast By Distribution Channel 4.1. Global Market Size and Forecast By Distribution Channel, 2023-2033 4.1.1. Hospital Pharmacies Market Size and Forecast, 2023-2033 4.1.1.1. Revenue (US$ Mn) Comparison, By Region 4.1.1.2. Market Share Comparison, By Region 4.1.1.3. Y-o-Y growth Comparison, By Region 4.1.2. Retail Pharmacies Market Size and Forecast, 2023-2033 4.1.2.1. Revenue (US$ Mn) Comparison, By Region 4.1.2.2. Market Share Comparison, By Region 4.1.2.3. Y-o-Y growth Comparison, By Region 4.1.3. Online Pharmacies Market Size and Forecast, 2023-2033 4.1.3.1. Revenue (US$ Mn) Comparison, By Region 4.1.3.2. Market Share Comparison, By Region 4.1.3.3. Y-o-Y growth Comparison, By Region 4.1.4. Drug Stores Market Size and Forecast, 2023-2033 4.1.4.1. Revenue (US$ Mn) Comparison, By Region 4.1.4.2. Market Share Comparison, By Region 4.1.4.3. Y-o-Y growth Comparison, By Region 5. Global Market Analysis and Forecast By Region 5.1. Global Market Size and Forecast, 2023-2033 5.1.1. North America Market Size and Forecast, 2023-2033 5.1.1.1. Revenue (US$ Mn) Comparison, By Indication 5.1.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel 5.1.2. Latin America Market Size and Forecast, 2023-2033 5.1.2.1. Revenue (US$ Mn) Comparison, By Indication 5.1.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel 5.1.3. Europe Market Size and Forecast, 2023-2033 5.1.3.1. Revenue (US$ Mn) Comparison, By Indication 5.1.3.2. Revenue (US$ Mn) Comparison, By Distribution Channel 5.1.4. Japan Market Size and Forecast, 2023-2033 5.1.4.1. Revenue (US$ Mn) Comparison, By Indication 5.1.4.2. Revenue (US$ Mn) Comparison, By Distribution Channel 5.1.5. APEJ Market Size and Forecast, 2023-2033 5.1.5.1. Revenue (US$ Mn) Comparison, By Indication 5.1.5.2. Revenue (US$ Mn) Comparison, By Distribution Channel 5.1.6. MEA Market Size and Forecast, 2023-2033 5.1.6.1. Revenue (US$ Mn) Comparison, By Indication 5.1.6.2. Revenue (US$ Mn) Comparison, By Distribution Channel 6. North America Market Analysis and Forecast, By Country, 2023-2033 6.1. US Market Size and Forecast, 2023-2033 6.1.1. Revenue (US$ Mn) Comparison, By Indication 6.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel 6.2. Canada Market Size and Forecast, 2023-2033 6.2.1. Revenue (US$ Mn) Comparison, By Indication 6.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel 7. Latin America Market Analysis and Forecast, By Country, 2023-2033 7.1. Brazil Market Size and Forecast, 2023-2033 7.1.1. Revenue (US$ Mn) Comparison, By Indication 7.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel 7.2. Mexico Market Size and Forecast, 2023-2033 7.2.1. Revenue (US$ Mn) Comparison, By Indication 7.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel 7.3. Argentina Market Size and Forecast, 2023-2033 7.3.1. Revenue (US$ Mn) Comparison, By Indication 7.3.2. Revenue (US$ Mn) Comparison, By Distribution Channel 8. Europe Market Analysis and Forecast, By Country, 2023-2033 8.1. Germany Market Size and Forecast, 2023-2033 8.1.1. Revenue (US$ Mn) Comparison, By Indication 8.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel 8.2. UK Market Size and Forecast, 2023-2033 8.2.1. Revenue (US$ Mn) Comparison, By Indication 8.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel 8.3. France Market Size and Forecast, 2023-2033 8.3.1. Revenue (US$ Mn) Comparison, By Indication 8.3.2. Revenue (US$ Mn) Comparison, By Distribution Channel 8.4. Spain Market Size and Forecast, 2023-2033 8.4.1. Revenue (US$ Mn) Comparison, By Indication 8.4.2. Revenue (US$ Mn) Comparison, By Distribution Channel 8.5. Italy Market Size and Forecast, 2023-2033 8.5.1. Revenue (US$ Mn) Comparison, By Indication 8.5.2. Revenue (US$ Mn) Comparison, By Distribution Channel 8.6. Nordic Market Size and Forecast, 2023-2033 8.6.1. Revenue (US$ Mn) Comparison, By Indication 8.6.2. Revenue (US$ Mn) Comparison, By Distribution Channel 9. Japan Market Analysis and Forecast, By Country, 2023-2033 9.1. Japan Market Size and Forecast, 2023-2033 9.1.1. Revenue (US$ Mn) Comparison, By Indication 9.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel 10. APEJ Market Analysis and Forecast, By Country, 2023-2033 10.1. China Market Size and Forecast, 2023-2033 10.1.1. Revenue (US$ Mn) Comparison, By Indication 10.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel 10.2. India Market Size and Forecast, 2023-2033 10.2.1. Revenue (US$ Mn) Comparison, By Indication 10.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel 10.3. Malaysia Market Size and Forecast, 2023-2033 10.3.1. Revenue (US$ Mn) Comparison, By Indication 10.3.2. Revenue (US$ Mn) Comparison, By Distribution Channel 10.4. Thailand Market Size and Forecast, 2023-2033 10.4.1. Revenue (US$ Mn) Comparison, By Indication 10.4.2. Revenue (US$ Mn) Comparison, By Distribution Channel 10.5. Singapore Market Size and Forecast, 2023-2033 10.5.1. Revenue (US$ Mn) Comparison, By Indication 10.5.2. Revenue (US$ Mn) Comparison, By Distribution Channel 10.6. Australia Market Size and Forecast, 2023-2033 10.6.1. Revenue (US$ Mn) Comparison, By Indication 10.6.2. Revenue (US$ Mn) Comparison, By Distribution Channel 11. MEA Market Analysis and Forecast, By Country, 2023-2033 11.1. GCC Countries Market Size and Forecast, 2023-2033 11.1.1. Revenue (US$ Mn) Comparison, By Indication 11.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel 11.2. South Africa Market Size and Forecast, 2023-2033 11.2.1. Revenue (US$ Mn) Comparison, By Indication 11.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel 11.3. Nigeria Market Size and Forecast, 2023-2033 11.3.1. Revenue (US$ Mn) Comparison, By Indication 11.3.2. Revenue (US$ Mn) Comparison, By Distribution Channel 11.4. Israel Market Size and Forecast, 2023-2033 11.4.1. Revenue (US$ Mn) Comparison, By Indication 11.4.2. Revenue (US$ Mn) Comparison, By Distribution Channel 12. Global Market Competition Landscape and Company Profile 12.1. Company Share Analysis By Region 12.1.1. Becton, Dickinson and Company 12.1.1.1. Company Overview 12.1.1.2. Market Indicationlist 12.1.1.3. Market IndicationSales Data and Key Financials 12.1.1.4. Key Developments 12.1.1.5. SWOT Analysis 12.1.2. Pfizer, Inc. 12.1.2.1. Company Overview 12.1.2.2. Market Indicationlist 12.1.2.3. Market IndicationSales Data and Key Financials 12.1.2.4. Key Developments 12.1.2.5. SWOT Analysis 12.1.3. Mylan N.V. 12.1.3.1. Company Overview 12.1.3.2. Market Indicationlist 12.1.3.3. Market IndicationSales Data and Key Financials 12.1.3.4. Key Developments 12.1.3.5. SWOT Analysis 12.1.4. Antares Pharma, Inc. 12.1.4.1. Company Overview 12.1.4.2. Market Indicationlist 12.1.4.3. Market IndicationSales Data and Key Financials 12.1.4.4. Key Developments 12.1.4.5. SWOT Analysis 12.1.5. Amgen Inc. 12.1.5.1. Company Overview 12.1.5.2. Market Indicationlist 12.1.5.3. Market IndicationSales Data and Key Financials 12.1.5.4. Key Developments 12.1.5.5. SWOT Analysis 12.1.6. Eli Lilly and Company 12.1.6.1. Company Overview 12.1.6.2. Market Indicationlist 12.1.6.3. Market IndicationSales Data and Key Financials 12.1.6.4. Key Developments 12.1.6.5. SWOT Analysis 13. Research Methodology 14. Secondary and Primary Sources 15. Assumptions and Acronyms 16. Disclaimer
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
TABLE 01: Global Market Value (US$ Mn), 2018-2022
TABLE 02: Global Market Value (US$ Mn), 2023-2033
TABLE 03: Global Market Value (US$ Mn) and Y-o-Y, 2023-2033
TABLE 04: Global Anaphylaxis Segment Value (US$ Mn), By Region 2018-2022
TABLE 05: Global Anaphylaxis Segment Value (US$ Mn), By Region 2023-2033
TABLE 06: Global Anaphylaxis Segment Market Share, By Region 2018-2022
TABLE 07: Global Anaphylaxis Segment Market Share, By Region 2023-2033
TABLE 08: Global Anaphylaxis Segment Y-o-Y, By Region 2023-2033
TABLE 09: Global Multiple Sclerosis Segment Value (US$ Mn), By Region 2018-2022
TABLE 10: Global Multiple Sclerosis Segment Value (US$ Mn), By Region 2023-2033
TABLE 11: Global Multiple Sclerosis Segment Market Share, By Region 2018-2022
TABLE 12: Global Multiple Sclerosis Segment Market Share, By Region 2023-2033
TABLE 13: Global Multiple Sclerosis Segment Y-o-Y, By Region 2023-2033
TABLE 14: Global Rheumatoid Arthritis Segment Value (US$ Mn), By Region 2018-2022
TABLE 15: Global Rheumatoid Arthritis Segment Value (US$ Mn), By Region 2023-2033
TABLE 16: Global Rheumatoid Arthritis Segment Market Share, By Region 2018-2022
TABLE 17: Global Rheumatoid Arthritis Segment Market Share, By Region 2023-2033
TABLE 18: Global Rheumatoid Arthritis Segment Y-o-Y, By Region 2023-2033
TABLE 19: Global Others Segment Value (US$ Mn), By Region 2018-2022
TABLE 20: Global Others Segment Value (US$ Mn), By Region 2023-2033
TABLE 21: Global Others Segment Market Share, By Region 2018-2022
TABLE 22: Global Others Segment Market Share, By Region 2023-2033
TABLE 23: Global Others Segment Y-o-Y, By Region 2023-2033
TABLE 24: Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2018-2022
TABLE 25: Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2023-2033
TABLE 26: Global Hospital Pharmacies Segment Market Share, By Region 2018-2022
TABLE 27: Global Hospital Pharmacies Segment Market Share, By Region 2023-2033
TABLE 28: Global Hospital Pharmacies Segment Y-o-Y, By Region 2023-2033
TABLE 29: Global Retail Pharmacies Segment Value (US$ Mn), By Region 2018-2022
TABLE 30: Global Retail Pharmacies Segment Value (US$ Mn), By Region 2023-2033
TABLE 31: Global Retail Pharmacies Segment Market Share, By Region 2018-2022
TABLE 32: Global Retail Pharmacies Segment Market Share, By Region 2023-2033
TABLE 33: Global Retail Pharmacies Segment Y-o-Y, By Region 2023-2033
TABLE 34: Global Online Pharmacies Segment Value (US$ Mn), By Region 2018-2022
TABLE 35: Global Online Pharmacies Segment Value (US$ Mn), By Region 2023-2033
TABLE 36: Global Online Pharmacies Segment Market Share, By Region 2018-2022
TABLE 37: Global Online Pharmacies Segment Market Share, By Region 2023-2033
TABLE 38: Global Online Pharmacies Segment Y-o-Y, By Region 2023-2033
TABLE 39: Global Drug Stores Segment Value (US$ Mn), By Region 2018-2022
TABLE 40: Global Drug Stores Segment Value (US$ Mn), By Region 2023-2033
TABLE 41: Global Drug Stores Segment Market Share, By Region 2018-2022
TABLE 42: Global Drug Stores Segment Market Share, By Region 2023-2033
TABLE 43: Global Drug Stores Segment Y-o-Y, By Region 2023-2033
TABLE 44: North America Market Value (US$ Mn), By Indication2018-2022
TABLE 45: North America Market Value (US$ Mn), By Indication2023-2033
TABLE 46: North America Market Value (US$ Mn), By Distribution Channel 2018-2022
TABLE 47: North America Market Value (US$ Mn), By Distribution Channel 2023-2033
TABLE 48: Latin America Market Value (US$ Mn), By Indication2018-2022
TABLE 49: Latin America Market Value (US$ Mn), By Indication2023-2033
TABLE 50: Latin America Market Value (US$ Mn), By Distribution Channel 2018-2022
TABLE 51: Latin America Market Value (US$ Mn), By Distribution Channel 2023-2033
TABLE 52: Europe Market Value (US$ Mn), By Indication2018-2022
TABLE 53: Europe Market Value (US$ Mn), By Indication2023-2033
TABLE 54: Europe Market Value (US$ Mn), By Distribution Channel 2018-2022
TABLE 55: Europe Market Value (US$ Mn), By Distribution Channel 2023-2033
TABLE 56: Japan Market Value (US$ Mn), By Indication2018-2022
TABLE 57: Japan Market Value (US$ Mn), By Indication2023-2033
TABLE 58: Japan Market Value (US$ Mn), By Distribution Channel 2018-2022
TABLE 59: Japan Market Value (US$ Mn), By Distribution Channel 2023-2033
TABLE 60: APEJ Market Value (US$ Mn), By Indication2018-2022
TABLE 61: APEJ Market Value (US$ Mn), By Indication2023-2033
TABLE 62: APEJ Market Value (US$ Mn), By Distribution Channel 2018-2022
TABLE 63: APEJ Market Value (US$ Mn), By Distribution Channel 2023-2033
TABLE 64: MEA Market Value (US$ Mn), By Indication2018-2022
TABLE 65: MEA Market Value (US$ Mn), By Indication2023-2033
TABLE 66: MEA Market Value (US$ Mn), By Distribution Channel 2018-2022
TABLE 67: MEA Market Value (US$ Mn), By Distribution Channel 2023-2033
TABLE 68: US Market Value (US$ Mn), By Indication2018-2022
TABLE 69: US Market Value (US$ Mn), By Indication2023-2033
TABLE 70: US Market Value (US$ Mn), By Distribution Channel 2018-2022
TABLE 71: US Market Value (US$ Mn), By Distribution Channel 2023-2033
TABLE 72: Canada Market Value (US$ Mn), By Indication2018-2022
TABLE 73: Canada Market Value (US$ Mn), By Indication2023-2033
TABLE 74: Canada Market Value (US$ Mn), By Distribution Channel 2018-2022
TABLE 75: Canada Market Value (US$ Mn), By Distribution Channel 2023-2033
TABLE 76: Brazil Market Value (US$ Mn), By Indication2018-2022
TABLE 77: Brazil Market Value (US$ Mn), By Indication2023-2033
TABLE 78: Brazil Market Value (US$ Mn), By Distribution Channel 2018-2022
TABLE 79: Brazil Market Value (US$ Mn), By Distribution Channel 2023-2033
TABLE 80: Mexico Market Value (US$ Mn), By Indication2018-2022
TABLE 81: Mexico Market Value (US$ Mn), By Indication2023-2033
TABLE 82: Mexico Market Value (US$ Mn), By Distribution Channel 2018-2022
TABLE 83: Mexico Market Value (US$ Mn), By Distribution Channel 2023-2033
TABLE 84: Argentina Market Value (US$ Mn), By Indication2018-2022
TABLE 85: Argentina Market Value (US$ Mn), By Indication2023-2033
TABLE 86: Argentina Market Value (US$ Mn), By Distribution Channel 2018-2022
TABLE 87: Argentina Market Value (US$ Mn), By Distribution Channel 2023-2033
TABLE 88: Germany Market Value (US$ Mn), By Indication2018-2022
TABLE 89: Germany Market Value (US$ Mn), By Indication2023-2033
TABLE 90: Germany Market Value (US$ Mn), By Distribution Channel 2018-2022
TABLE 91: Germany Market Value (US$ Mn), By Distribution Channel 2023-2033
TABLE 92: UK Market Value (US$ Mn), By Indication2018-2022
TABLE 93: UK Market Value (US$ Mn), By Indication2023-2033
TABLE 94: UK Market Value (US$ Mn), By Distribution Channel 2018-2022
TABLE 95: UK Market Value (US$ Mn), By Distribution Channel 2023-2033
TABLE 96: France Market Value (US$ Mn), By Indication2018-2022
TABLE 97: France Market Value (US$ Mn), By Indication2023-2033
TABLE 98: France Market Value (US$ Mn), By Distribution Channel 2018-2022
TABLE 99: France Market Value (US$ Mn), By Distribution Channel 2023-2033
TABLE 100: Spain Market Value (US$ Mn), By Indication2018-2022
TABLE 101: Spain Market Value (US$ Mn), By Indication2023-2033
TABLE 102: Spain Market Value (US$ Mn), By Distribution Channel 2018-2022
TABLE 103: Spain Market Value (US$ Mn), By Distribution Channel 2023-2033
TABLE 104: Italy Market Value (US$ Mn), By Indication2018-2022
TABLE 105: Italy Market Value (US$ Mn), By Indication2023-2033
TABLE 106: Italy Market Value (US$ Mn), By Distribution Channel 2018-2022
TABLE 107: Italy Market Value (US$ Mn), By Distribution Channel 2023-2033
TABLE 108: Nordic Market Value (US$ Mn), By Indication2018-2022
TABLE 109: Nordic Market Value (US$ Mn), By Indication2023-2033
TABLE 110: Nordic Market Value (US$ Mn), By Distribution Channel 2018-2022
TABLE 111: Nordic Market Value (US$ Mn), By Distribution Channel 2023-2033
TABLE 112: Japan Market Value (US$ Mn), By Indication2018-2022
TABLE 113: Japan Market Value (US$ Mn), By Indication2023-2033
TABLE 114: Japan Market Value (US$ Mn), By Distribution Channel 2018-2022
TABLE 115: Japan Market Value (US$ Mn), By Distribution Channel 2023-2033
TABLE 116: China Market Value (US$ Mn), By Indication2018-2022
TABLE 117: China Market Value (US$ Mn), By Indication2023-2033
TABLE 118: China Market Value (US$ Mn), By Distribution Channel 2018-2022
TABLE 119: China Market Value (US$ Mn), By Distribution Channel 2023-2033
TABLE 120: India Market Value (US$ Mn), By Indication2018-2022
TABLE 121: India Market Value (US$ Mn), By Indication2023-2033
TABLE 122: India Market Value (US$ Mn), By Distribution Channel 2018-2022
TABLE 123: India Market Value (US$ Mn), By Distribution Channel 2023-2033
TABLE 124: Malaysia Market Value (US$ Mn), By Indication2018-2022
TABLE 125: Malaysia Market Value (US$ Mn), By Indication2023-2033
TABLE 126: Malaysia Market Value (US$ Mn), By Distribution Channel 2018-2022
TABLE 127: Malaysia Market Value (US$ Mn), By Distribution Channel 2023-2033
TABLE 128: Thailand Market Value (US$ Mn), By Indication2018-2022
TABLE 129: Thailand Market Value (US$ Mn), By Indication2023-2033
TABLE 130: Thailand Market Value (US$ Mn), By Distribution Channel 2018-2022
TABLE 131: Thailand Market Value (US$ Mn), By Distribution Channel 2023-2033
TABLE 132: Singapore Market Value (US$ Mn), By Indication2018-2022
TABLE 133: Singapore Market Value (US$ Mn), By Indication2023-2033
TABLE 134: Singapore Market Value (US$ Mn), By Distribution Channel 2018-2022
TABLE 135: Singapore Market Value (US$ Mn), By Distribution Channel 2023-2033
TABLE 136: Australia Market Value (US$ Mn), By Indication2018-2022
TABLE 137: Australia Market Value (US$ Mn), By Indication2023-2033
TABLE 138: Australia Market Value (US$ Mn), By Distribution Channel 2018-2022
TABLE 139: Australia Market Value (US$ Mn), By Distribution Channel 2023-2033
TABLE 140: GCC Countries Market Value (US$ Mn), By Indication2018-2022
TABLE 141: GCC Countries Market Value (US$ Mn), By Indication2023-2033
TABLE 142: GCC Countries Market Value (US$ Mn), By Distribution Channel 2018-2022
TABLE 143: GCC Countries Market Value (US$ Mn), By Distribution Channel 2023-2033
TABLE 144: South Africa Market Value (US$ Mn), By Indication2018-2022
TABLE 145: South Africa Market Value (US$ Mn), By Indication2023-2033
TABLE 146: South Africa Market Value (US$ Mn), By Distribution Channel 2018-2022
TABLE 147: South Africa Market Value (US$ Mn), By Distribution Channel 2023-2033
TABLE 148: Nigeria Market Value (US$ Mn), By Indication2018-2022
TABLE 149: Nigeria Market Value (US$ Mn), By Indication2023-2033
TABLE 150: Nigeria Market Value (US$ Mn), By Distribution Channel 2018-2022
TABLE 151: Nigeria Market Value (US$ Mn), By Distribution Channel 2023-2033
TABLE 152: Israel Market Value (US$ Mn), By Indication2018-2022
TABLE 153: Israel Market Value (US$ Mn), By Indication2023-2033
TABLE 154: Israel Market Value (US$ Mn), By Distribution Channel 2018-2022
TABLE 155: Israel Market Value (US$ Mn), By Distribution Channel 2023-2033
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
FIG. 01: Global Market Value (US$ Mn), 2018-2022
FIG. 02: Global Market Value (US$ Mn) Forecast, 2023-2033
FIG. 03: Global Market Value (US$ Mn) and Y-o-Y, 2023-2033
FIG. 04: Global Anaphylaxis Segment Market Value (US$ Mn) By Region, 2018-2022
FIG. 05: Global Anaphylaxis Segment Market Value (US$ Mn) By Region, 2023-2033
FIG. 06: Global Anaphylaxis Segment Y-o-Y Growth Rate, By Region, 2023-2033
FIG. 07: Global Multiple Sclerosis Segment Market Value (US$ Mn) By Region, 2018-2022
FIG. 08: Global Multiple Sclerosis Segment Market Value (US$ Mn) By Region, 2023-2033
FIG. 09: Global Multiple Sclerosis Segment Y-o-Y Growth Rate, By Region, 2023-2033
FIG. 10: Global Rheumatoid Arthritis Segment Market Value (US$ Mn) By Region, 2018-2022
FIG. 11: Global Rheumatoid Arthritis Segment Market Value (US$ Mn) By Region, 2023-2033
FIG. 12: Global Rheumatoid Arthritis Segment Y-o-Y Growth Rate, By Region, 2023-2033
FIG. 13: Global Others Segment Market Value (US$ Mn) By Region, 2018-2022
FIG. 14: Global Others Segment Market Value (US$ Mn) By Region, 2023-2033
FIG. 15: Global Others Segment Y-o-Y Growth Rate, By Region, 2023-2033
FIG. 16: Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2018-2022
FIG. 17: Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2023-2033
FIG. 18: Global Hospital Pharmacies Segment Y-o-Y Growth Rate, By Region, 2023-2033
FIG. 19: Global Retail Pharmacies Segment Market Value (US$ Mn) By Region, 2018-2022
FIG. 20: Global Retail Pharmacies Segment Market Value (US$ Mn) By Region, 2023-2033
FIG. 21: Global Retail Pharmacies Segment Y-o-Y Growth Rate, By Region, 2023-2033
FIG. 22: Global Online Pharmacies Segment Market Value (US$ Mn) By Region, 2018-2022
FIG. 23: Global Online Pharmacies Segment Market Value (US$ Mn) By Region, 2023-2033
FIG. 24: Global Online Pharmacies Segment Y-o-Y Growth Rate, By Region, 2023-2033
FIG. 25: Global Drug Stores Segment Market Value (US$ Mn) By Region, 2018-2022
FIG. 26: Global Drug Stores Segment Market Value (US$ Mn) By Region, 2023-2033
FIG. 27: Global Drug Stores Segment Y-o-Y Growth Rate, By Region, 2023-2033
FIG. 28: North America Market Value (US$ Mn), By Indication2018-2022
FIG. 29: North America Market Value (US$ Mn), By Indication2023-2033
FIG. 30: North America Market Value (US$ Mn), By Distribution Channel 2018-2022
FIG. 31: North America Market Value (US$ Mn), By Distribution Channel 2023-2033
FIG. 32: Latin America Market Value (US$ Mn), By Indication2018-2022
FIG. 33: Latin America Market Value (US$ Mn), By Indication2023-2033
FIG. 34: Latin America Market Value (US$ Mn), By Distribution Channel 2018-2022
FIG. 35: Latin America Market Value (US$ Mn), By Distribution Channel 2023-2033
FIG. 36: Europe Market Value (US$ Mn), By Indication2018-2022
FIG. 37: Europe Market Value (US$ Mn), By Indication2023-2033
FIG. 38: Europe Market Value (US$ Mn), By Distribution Channel 2018-2022
FIG. 39: Europe Market Value (US$ Mn), By Distribution Channel 2023-2033
FIG. 40: Japan Market Value (US$ Mn), By Indication2018-2022
FIG. 41: Japan Market Value (US$ Mn), By Indication2023-2033
FIG. 42: Japan Market Value (US$ Mn), By Distribution Channel 2018-2022
FIG. 43: Japan Market Value (US$ Mn), By Distribution Channel 2023-2033
FIG. 44: APEJ Market Value (US$ Mn), By Indication2018-2022
FIG. 45: APEJ Market Value (US$ Mn), By Indication2023-2033
FIG. 46: APEJ Market Value (US$ Mn), By Distribution Channel 2018-2022
FIG. 47: APEJ Market Value (US$ Mn), By Distribution Channel 2023-2033
FIG. 48: MEA Market Value (US$ Mn), By Indication2018-2022
FIG. 49: MEA Market Value (US$ Mn), By Indication2023-2033
FIG. 50: MEA Market Value (US$ Mn), By Distribution Channel 2018-2022
FIG. 51: MEA Market Value (US$ Mn), By Distribution Channel 2023-2033
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the current size of the global prefilled auto injectors market?
The global prefilled auto injectors market accounts for US$ 4.2 billion in 2023.
How big will the prefilled auto injectors market be by 2033?
By 2033-end, demand for prefilled auto injectors is projected to rake in a revenue of US$ 17 billion.
What is the prefilled auto injectors market growth?
Prefilled auto injector demand is forecasted to rise at a stellar 15% CAGR over the next ten years.
What are the top trends in the prefilled auto injectors market?
Development and launch of advanced auto injectors and increasing incidence of allergic reactions are key trends in the industry.
Who are the top industry players in the global prefilled auto injectors market?
Becton Dickinson and Company, Medtronic, Pfizer Inc., Gerresheimer, Mylan N.V., and Amgen Inc. are leading manufacturers of prefilled auto injectors.
Prefilled Auto Injectors Market